Adverum Biotechnologies Inc. priced an offering of 8,888,900 shares at $6.75 apiece to raise about $60 million in gross proceeds.
Cowen and Piper Jaffray & Co. are acting as joint book-running managers of the offering which is expected to close by Feb. 9. Raymond James is acting as lead manager.
The Menlo Park, Calif.-based company has granted the underwriters an option to purchase up to an additional 1,333,335 shares.
